Dr. L.E. (Loes) Visser

• PharmD, RUG, 29-6-1995
• MSc Clinical Epidemiology, NIHES, Erasmus University, 20-6-2003.
• Registration as Epidemiologist B, 30-1-2006
• Dept. Pharmacy, hospital St. Jansdal, 1995-1996.
• Dept. Pharmacy, Radboud UMC, 1996.
• Apotheek Haagse Ziekenhuizen (AHZ), hospital pharmacy resident, 1996-1999.
• Dept. Pharmacy, Erasmus MC, 2000-2013
• Dept. Epidemiology & Internal medicine, 2000-2020
• Dept. Pharmacy, Haga Teaching hospital, 2013-now
• Dept. Pharmacy, Erasmus MC, 2021-now.

Thesis supervision:

• Claire Siemes, Erasmus MC, Rotterdam. Title thesis: “New insights into genetic variation and cancer” (May 9, 2007).
• Matthijs Becker, Erasmus MC, Rotterdam. Title thesis: “Individualizing pharmacotherapy. Genetic factors and co-prescribed drugs affecting pharmacotherapy” (Nov 4, 2009).
• Monique Bijl, Erasmus MC, Rotterdam. Title thesis: “The influence of the CYP2D6*4 polymorphism on drug response and disease susceptibility” (Nov 20, 2009).
• Martina Teichert, Erasmus MC, Rotterdam. Title thesis: “Pharmacogenetic aspects and drug interactions in anticoagulation therapy with coumarins” (Feb 18, 2011).
• Rikje Ruiter, Erasmus MC, Rotterdam. Title thesis: “Pharmaco-epidemiology as a tool in Pharmacovigilance: studying cancer as adverse drug reaction” (Feb 1, 2012).
• Eline Rodenburg, Erasmus MC, Rotterdam. Title thesis: “Sex differences in cardiovascular drug response” (Sep 18, 2012).
• Catherina de Keyser, Erasmus MC, Rotterdam. Title thesis: “Pharmacogenetic Epidemiology of Statins in an Ageing Population” (Jun 5, 2015).
• Raymond Noordam, Erasmus MC, Rotterdam. Title thesis: “Pharmacoepidemiological studies on antidepressant use in older adults” (July 3, 2015).
• Nikkie Aarts, Erasmus MC, Rotterdam. Title thesis: “Utilization and unintended effects of antidepressants in an ageing population” (Dec 16, 2015).
• Kiki Cheung, Erasmus MC, Rotterdam. Title thesis: “Medication use in children and adolescents. Studies using different information sources” (May 12, 2020).

Ongoing thesis supervision:

• Edwin Brokaar, Haga Teaching hospital: medication optimisation and medication safety in elderly cancer patients.
• Linda Hendriksen, Erasmus MC, Rotterdam: sex as a risk factor for serious adverse drug reactions.

  Teaching:

• Course on research methodology for hospital pharmacy residents (CORAZ), NVZA, once a year.
• Teaching program Clinical pharmacology for residents in paediatrics and in hospital pharmacy, Haga Teaching hospital.
• Module ‘Gender-specific pharmacotherapy’, Master Farmacy, LUMC, once a year.

• Hospital pharmacist Haga Teaching hospital, responsible for clinical trials, research & teaching.
• Board member MSC (medical staff), Haga Teaching hospital.
• Secretary scientific committee NVZA (CWZO).
• Board member CGR.
• Clinical pharmacologist in training, Haga Teaching hospital.

Grants (principal investigator):

• ZonMw, Gender and Health, 2017, €169.000
• KWF, Beleidsproject kanker en ouderen, 2015, €88.100
• ZonMw, Priority medicines Ouderen, 2010, €570.000
• Min. VWS, patient safety program, 2004, € 150.000.

   

  Grants (co-investigator):

• Hartstichting, sekse-specifieke werking cardiovasculaire gnm, 2017, €104.662
• NWO, Maatschappelijk Verantwoord Innoveren (MVI), 2015, €235.000
• ZonMw, Dure en Weesgeneesmiddelen, 2010, €434.349.

   

  Awards:

• Sanofi Award for best original research paper NVZA, 21-10-2013
• Pierre Wijermans award for best scientific department, 2018, Haga Teaching hospital.
• Corrie Hermann award 2019, VNVA.